Los Angeles Times (LT) - Thursday January 29, 1998 Page: 2 Pt. E
Pamela Warrick; Times Staff Writer
At the Hard Candy cosmetics company in Beverly Hills, love is a shimmering, pearlized white that gleams like a sunbeam caught in a raindrop.
"Love" is the newest hue in the 60-color spectrum of Hard Candy nail polishes. And it apparently is the first nail lacquer to be created solely to save lives. When the special edition color goes on sale in stores Sunday, Hard Candy founder Dineh Mohajer will kick off a personal campaign to raise $100,000 to help women with AIDS.
On the front of each bottle of "Love" polish will be a logo of the red AIDS ribbon. All proceeds from sales of every $12 bottle will be donated to AMFAR, the AIDS charity that supports medical research and other services for people living with HIV and AIDS.
"The number of women contracting HIV is rising," says Mohajer. "Twelve years ago, only 7% of AIDS victims in the U.S. were women. Now, it's 20%."
As a former medical student, Mohajer has a special interest in health issues. During a summer between semesters, she mixed up a batch of pale blue nail polish to match her favorite strappy sandals. When strangers asked where they could buy it, she made up a few pastel polishes and put them on a counter at the Fred Segal store.
The fresh colors were an instant hit, first with preteens and then with their mothers. And along the way, Hard Candy caught the eye of such celebrities as Gwyneth Paltrow, Cher, Alicia Silverstone and Elton John. In early 1997, the company launched Candy Man, the first line of polish marketed specifically for men.
The company founded by a 23-year-old USC coed who mixed nail colors in her bathroom is now, 2 1/2 years later, worth $10 million.
Mohajer has high hopes for her special edition. "Whenever I put names to these colors, I always take votes. But with this one, there was no question."
That is true "Love."
CAPTION: Photo: (No Caption) GARY FRIEDMAN / Los Angeles Times
Copyright © 1998 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .